Endonovo Therapeutics, Inc.
ENDV
Revenue
1.52k
▼-43.68k▼-96.64%
3 Months ChangeAssets
815.76k
▼-199.06k▼-19.61%
3 Months ChangeLiabilities
23.78M
▲559.31k▲2.41%
3 Months ChangeFree Cash Flow
-599.72k
▼-599.72k-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-01-03
Form 8-K
ID: 0001493152-24-000339
2023-12-29
Form 10-Q
ID: 0001493152-23-046444
2023-12-04
Form 8-K
ID: 0001493152-23-043516
2023-10-12
Form 8-K
ID: 0001493152-23-036971
2023-08-21
Form 10-Q
ID: 0001493152-23-029706
2023-05-22
Form 10-Q
ID: 0001493152-23-018538
2023-03-29
Form 8-K
ID: 0001493152-23-009376
2022-11-21
Form 10-Q
ID: 0001493152-22-033118
2022-09-27
Form 8-K
ID: 0001493152-22-026882
2022-08-22
Form 10-Q
ID: 0001493152-22-023661